相关实验视频
Updated: Jun 5, 2025

14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
10.9K
一项模拟研究,以评估人口药理动力学模型选择对新生儿万科米辛初始剂量推的影响
Mehdi El Hassani1,2, Mathieu Blouin1,2, Amélie Marsot1,2
1Faculté de pharmacie, Université de Montréal, Canada.
British journal of clinical pharmacology
|December 4, 2024
概括
选择最好的万科米辛群体药理动力学 (popPK) 模型对于准确的新生儿剂量至关重要. 具有更好的预测性能的模型导致目标实现 (PTA) 的概率更高,尽管偏差和不准确的影响较小.
科学领域:
- 制药指标 (Pharmacometrics) 是一个指标.
- 新生儿药理学 新生儿药理学
- 药物剂量优化 药物剂量优化
背景情况:
- 在新生儿中,准确的万科米辛剂量对于治疗成功和最大限度地减少毒性至关重要.
- 基于模型的精确剂量 (MIPD) 取决于选择适当的种群药理动力学 (popPK) 模型.
- 在popPK模型中的可变性可能会导致低于最佳的初始剂量策略.
研究的目的:
- 评估在多个新生儿popPK模型中关于最佳初始万科米辛剂量的协议.
- 评估模型预测性能对目标实现概率 (PTA) 的影响.
主要方法:
- 一个虚拟的新生儿群体被模拟使用26个外部万科米辛popPK模型.
- 模拟了五种剂量方案,以确定最佳的初始剂量和计算PTA.
- 多重回归分析探讨了模型性能和PTA之间的关系.
主要成果:
- 对于大多数 (15/26) 范科米辛popPK模型,对最佳的初始剂量方案达成共识.
- 具有卓越的先验预测性能的模型获得了最高的PTA.
- 模型的不精确性,但不是偏差,显著影响了PTA,解释了一小部分的变化.
结论:
- 尽管模型之间存在差异,但对于新生儿的初始万科米辛剂量存在共识.
- 优先考虑具有强大的预测性能的模型是优化新生儿万科米辛治疗的关键.
- 模型性能指标,特别是不精确性,对PTA变化提供了有限的洞察力.
相关概念视频
Analysis of Population Pharmacokinetic Data
232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232
Pharmacokinetic Models: Comparison and Selection Criterion
38
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
38
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
81
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
81
One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation
387
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
On...
387
One-Compartment Open Model for IV Bolus Administration: General Considerations
158
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
158

